JOHNSON RAYMOND M has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1976. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, measurement and electrical machinery and energy are ANIMAL & PLANT INSPECTION & QUARANTINE TECH CT SHE, NARIMATSU HISASHI and ODYSSEY PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Canada | 1 | |
#3 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Electrical machinery and energy | |
#4 | Pharmaceuticals | |
#5 | Engines, pumps and turbines | |
#6 | Machines | |
#7 | Furniture and games | |
#8 | Agriculture |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Microorganisms | |
#3 | Measuring microorganism processes | |
#4 | Peptides | |
#5 | Animal care | |
#6 | Unspecified technologies | |
#7 | Non-positive-displacement pumps | |
#8 | Special furniture | |
#9 | Therapeutic chemical compounds | |
#10 | Dynamo-electric machines |
# | Name | Total Patents |
---|---|---|
#1 | Johnson Raymond M | 12 |
#2 | Sadler Christopher | 1 |
#3 | Buttery Tim P | 1 |
Publication | Filing date | Title |
---|---|---|
US2017363626A1 | Methods and antisera for isolating and identifying subsets of CD8 T cells | |
US2017002419A1 | Diagnostic and immunotherapy compositions and methods for disease states mediated by inhibitor-resistant CD8 T-cells | |
US2015252420A1 | Methods of isolating and purifying CD8 T cells | |
US2014274783A1 | Chlamydia-specific cd8+ t cells and methods of isolating | |
US2014235543A1 | Methods for isolating and using a subset of cd8 t-cells that are resistant to inhibitors | |
US2013047274A1 | CD4 T-cells and CD8zeta cells involved in mammalian host response to epithelial cell infections and uses thereof | |
US4108515A | Display case |